Literature DB >> 3137055

Bactericidal activity of BMY-28100 versus amoxicillin/clavulanic acid against Branhamella catarrhalis.

E Yourassowsky1, M P Van der Linden, M J Lismont, F Crokaert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3137055     DOI： 10.1007/bf01962359

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  4 in total

1.  Comparative antibacterial activity of the new oral cephalosporin BMY-28100.

Authors:  F H Kayser
Journal:  Eur J Clin Microbiol       Date:  1987-06       Impact factor: 3.267

2.  BMY 28100, a new oral cephalosporin.

Authors:  F Leitner; T A Pursiano; R E Buck; Y H Tsai; D R Chisholm; M Misiek; J V Desiderio; R E Kessler
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

3.  Comparative in vitro activity of the new oral cephalosporin BMY-28100.

Authors:  K E Aldridge; D D Schiro; C V Sanders
Journal:  Eur J Clin Microbiol       Date:  1987-04       Impact factor: 3.267

4.  The incidence and antibiotic susceptibility of Branhamella catarrhalis in respiratory infections.

Authors:  M A Calder; M J Croughan; D T McLeod; F Ahmad
Journal:  Drugs       Date:  1986       Impact factor: 9.546
  4 in total
  1 in total

Review 1.  Branhamella catarrhalis: an organism gaining respect as a pathogen.

Authors:  B W Catlin
Journal:  Clin Microbiol Rev       Date:  1990-10       Impact factor: 26.132
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.